TREATMENT OF RECURRENT MALIGNANT PLEURAL EFFUSION

被引:80
作者
AUSTIN, EH
FLYE, MW
机构
[1] Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0003-4975(10)63779-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Effective control of a recurrent malignant pleural effusion can greatly improve the quality of life of the cancer patient. At least a dozen different techniques have been advocated for controlling this common complication of malignant disease. The present review collects and examines the clinical results of all techniques designed to treat this problem. The pathophysiology and diagnostic evaluation of the effusion are also discussed. On the basis of comparisons involving effectiveness, morbidity, and convenience, we recommend intrapleurally administered tetracycline with thoracostomy drainage as the technique of choice. Instillation of a talc suspension with thoracostomy drainage is also a safe and effective technique and should be employed when tetracycline fails or is contraindicated. © 1979, The Society of Thoracic Surgeons. All rights reserved.
引用
收藏
页码:190 / 203
页数:14
相关论文
共 117 条
[1]   TREATMENT OF MALIGNANT PLEURAL EFFUSION - METHOD USING TUBE THORACOSTOMY AND TALC [J].
ADLER, RH ;
SAYEK, I .
ANNALS OF THORACIC SURGERY, 1976, 22 (01) :8-15
[2]   MECHANICS OF PLEURAL SPACE [J].
AGOSTONI, E .
PHYSIOLOGICAL REVIEWS, 1972, 52 (01) :57-&
[3]  
ALBERTELLI J, 1954, PRENSA MED ARGENT, V41, P201
[4]  
ALDER RH, 1967, SURGERY, V62, P1000
[5]   INTRACAVITARY THIOTEPA IN MALIGNANT PLEURAL AND PERITONEAL EFFUSIONS [J].
ANDERSEN, AP ;
BRINCKER, H .
ACTA RADIOLOGICA-THERAPY PHYSICS BIOLOGY, 1968, 7 (05) :369-&
[6]  
ANDERSON CB, 1974, CANCER-AM CANCER SOC, V33, P916, DOI 10.1002/1097-0142(197404)33:4<916::AID-CNCR2820330405>3.0.CO
[7]  
2-U
[8]   INTRACAVITARY COLLOIDAL RADIOGOLD IN THE TREATMENT OF EFFUSIONS CAUSED BY MALIGNANT NEOPLASMS [J].
ANDREWS, GA ;
ROOT, SW ;
KERMAN, HD ;
BIGELOW, RR .
ANNALS OF SURGERY, 1953, 137 (03) :375-381
[9]  
ARIEL IM, 1966, CANCER-AM CANCER SOC, V19, P1096, DOI 10.1002/1097-0142(196608)19:8<1096::AID-CNCR2820190808>3.0.CO
[10]  
2-N